Article
CDK8 and CDK19 kinases have non-redundant oncogenic functions in hepatocellular carcinoma
2019-10-01
Abstract excerpt
Hepatocellular carcinoma (HCC) is a common cancer with high mortality. The limited therapeutic options for advanced disease include treatment with Sorafenib, a multi-kinase inhibitor whose targets include the Mediator kinase CDK8. Since CDK8 has reported oncogenic activity in Wnt-dependent colorectal cancer, we investigated whether it is also involved in HCC. We find that CDK8 and its paralogue CDK19 are significa...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2abfde29-05a8-5d34-a6e0-943da6647058
- DOI
- 10.1101/789586
